Published Date: 14 Jan 2025
Incidence of cytokine release syndrome was minimal with the investigational therapy
Read Full NewsProposed federal student loan caps will drive students into pricier private loans, or derail their aspirations of becoming PAs, creating professional healthcare shortages.
The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving scanning access through...
Researchers at Spain's University of Granada have developed an artificial cornea made from the scales of several fish species commonly found in markets, which could become...
Activity restriction does not appear to lower the risk for preterm birth in pregnant women with a short cervix; it may even have the opposite effect.
The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on oil facilities could cause respiratory problems.
A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, the Washington Post reported on Wednesday, citing two people familiar with the...
In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.
1.
Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone
2.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
3.
Screening for prostate cancer: is it time to give up digital rectal examination?
4.
Surgeons are at higher risk of cancer, study suggests
5.
United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.
1.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
2.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
3.
Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation